Policy meetings

DRIVE-ABDRIVE-AB conference: Stimulating innovation, sustainable use and global access to antibiotics

2-3 June 2016, Amsterdam, NL

This conference, generously funded by the Government of the Netherlands and organized by the IMI DRIVE AB consortium, will bring together decision-makers and policy influencers from around the world to explore current and proposed efforts to address antibiotic resistance. The main goal of the meeting is to move beyond discussions and instead identify key policies that can be implemented globally to both stimulate the innovation of critically-needed new treatments and ensure their availability and responsible use. Input from the conference will help inform DRIVE AB’s policy recommendations to the European Commission—an important part of growing global discussion on how to manage the looming public health threat of resistance.

Programme

Policy Brief: The Necessity for Greater Antibiotic Innovation

 

DNDiWHOGlobal Antibiotic R&D (GARD) Partnership

A joint WHO/DNDi initiative incubated by DNDi in support of the Global Action Plan for Antimicrobial Resistance: Developing new antibiotic treatments, promoting responsible use, and ensuring access for all

Consultation

GARD Launch Event

 

EMAEMA Workshop on the use of pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products

12 – 13 November 2015

Presentations

Public consultation on the Guideline on the use of pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products. Comments by EPASG

tatfar2015Transatlantic Task Force on Antimicrobial Resistance (TATFAR)

Program

Presentations

The purpose of the biennial in-person TATFAR meeting is to fortify relationships and collaborations on activities relating to antimicrobial resistance (AMR). The meeting brings together representatives from institutional members of TATFAR from the European Union (EU) and the U.S., as well as representatives of the EU/European Economic Area Member States and Canada.  With the increasing importance of antimicrobial resistance globally, this meeting will serve a critical role in assessing TATFAR’s work to date, reviewing other international AMR initiatives, and shaping TATFAR’s future involvement with related AMR efforts.

Advertisements